MLchartDataset catalogue

clazakizumab

Term · Oncology and biomedicine · MLC-T-ONC-012631

A humanized monoclonal antibody directed against the pro-inflammatory cytokine interleukin-6 (Il-6) with potential immunomodulating activity. Upon administration, clazakizumab binds to and blocks the activity of IL-6, which may mitigate the catabolic effects of IL-6.

Table 1. Record
IdentifierMLC-T-ONC-012631
FieldOncology and biomedicine
Synonymsanti-IL6 monoclonal antibody ALD518
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012631",
  "term": "clazakizumab",
  "field": "Oncology and biomedicine",
  "definition": "A humanized monoclonal antibody directed against the pro-inflammatory cytokine interleukin-6 (Il-6) with potential immunomodulating activity. Upon administration, clazakizumab binds to and blocks the activity of IL-6, which may mitigate the catabolic effects of IL-6.",
  "synonyms": [
    "anti-IL6 monoclonal antibody ALD518"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/clazakizumab/"
}

Record 4,930 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.